Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3535-3550
Author(s):
Parvathi Menon, Matthew C. Kiernan and Steve Vucic
Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3508-3534
Author(s):
Livia Pasquali, Paola Lenzi, Francesca Biagioni, Gabriele Siciliano and Francesco Fornai
Magnetite Nanostructures with Applications in Cancer Therapy
Journal:
Current Proteomics
Volume:
11
Page:
128-138
Author(s):
Roxana Cristina Popescu and Alexandru Mihai Grumezescu
Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Journal:
Current Molecular Imaging (Discontinued)
Volume:
3
Page:
52-63
Author(s):
Tarik Z. Belhocine and Jean-Luc Vanderheyden
Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Journal:
Mini-Reviews in Organic Chemistry
Volume:
11
Page:
262-268
Author(s):
Roman Paduch and Martyna Kandefer-Szerszen
Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Journal:
Current Drug Targets
Volume:
15
Page:
973-981
Author(s):
Katsuhiko Takahashi, Taiki Shimizu, Keita Kosaka, Masafumi Hidaka, Chiyoko Uchida and Takafumi Uchida
Signaling Epicenters: The Role of Caveolae and Caveolins in Volatile Anesthetic Induced Cardiac Protection
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5681-5689
Author(s):
Yousuke T. Horikawa, Yasuo M. Tsutsumi, Hemal H. Patel and David M. Roth
MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5336-5347
Author(s):
Qiong Wu, Zhiping Yang, Yongquan Shi and Daiming Fan
microRNAs as Anti-Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5328-5335
Author(s):
Michela Garofalo, Gianpiero Di Leva and Carlo M. Croce
Targeting miRNAs for Pancreatic Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5279-5286
Author(s):
Min Shi, DachengXie, Yong Gaod and Keping Xie